Completed PHASE2 INTERVENTIONAL 2-arm NCT00506298

Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes

A Randomized, Multi-Center Study to Compare the Effects of CRx-401 to Bezafibrate Plus Placebo on Plasma Glucose Levels When Given to Subjects With Type II Diabetes on Metformin.

Sponsor: Zalicus

Conditions Type 2 Diabetes

Interventions bezafibrate + diflunisal bezafibrate + placebo

Updated 6 times since 2017 Last updated: May 12, 2009 Started: Jul 31, 2007 Primary completion: Apr 30, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Type 2 Diabetes and is currently completed. Zalicus leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zalicus

Data source: Zalicus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aylmer, Canada , Bay Roberts, Canada , Burlington, Canada , Chilliwack, Canada , Collingwood, Canada , Corunna, Canada , Greater Sudbury, Canada , Holyroad, Canada , London, Canada , Montreal, Canada and 7 more locations